Back Stocks profile

Stock analysis tool for investors

Cipla Ltd.

NSE: CIPLA | BSE:500087

₹1470.90 -9.45 (-0.64%) 1D

Pharmaceuticals & Biotechnology

Open an Account with Bigul in 5 minutes

Performance

Today’s low

1460.00

Today’s High

1494.00

52W low

852.00

52W High

1494.00

Open Price

1494.00

Prev. Close

1480.3500

Volume

2006094.00

Value

2950763664.60

Fundamentals

Market Cap Cr

118755.40

Price to Earnings

32.10

Price to Book Value

5.00

Dividend Yield

0.60

PE to Growth

0.80

Op Revenue TTM Cr

25350.15

Net Profit TTM Cr

3704.02

Cash From Operating Activity Cr

3237.65

Return on Equity %

11.96

EMA & SMA

Bullish Moving Averages

14

Bearish Moving Averages

2

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

01 Mar, 2024

65.4

Week

70.2

Month

54.2

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

1474.97

PIVOT

First Resistance

1489.93

Second Resistance

1508.97

Third Resistance

1523.93

First Support

1455.93

Second Support

1440.97

Third Support

1421.93

Relative Strength Index

61.22

Money Flow Index

39.17

MACD

32.1

MACD Signal

34.33

Average True Range

32.47

Average Directional Index

31.84

Rate of Change (21)

6

Rate of Change (125)

16.96

Commodity Channel Index

99.8

Williams %R

-27.6

BETA

1 Month

0.08

3 Month

-0.24

1 Year

0.01

3 Year

0.05

PRICE CHANGE ANALYSIS

0.31%

1 Week

Low

High

1451.4

1494

6%

1 Month

Low

High

1385

1494

22%

3 Months

Low

High

1192.1

1494

18.11%

6 Months

Low

High

1132

1494

63.51%

1 Year

Low

High

852

1494

Bigul
01 Mar 2024

CIPLA LTD. - 500087 - Update On Transfer Of Generics Business Undertaking Of The Company To Cipla Pharma And Life Sciences Limited, Wholly Owned Subsidiary

Update on transfer of Generics Business Undertaking of the Company to Cipla Pharma and Life Sciences Limited, wholly owned subsidiary of the Company
Bigul
01 Mar 2024

CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

Update on incorporation of a joint venture company in USA
Bigul
01 Mar 2024

CIPLA LTD. - 500087 - USFDA Inspection At Manufacturing Facility In Qidong, Jiangsu Province, China

USFDA inspection at manufacturing facility in Qidong, Jiangsu Province, China
Bigul
01 Mar 2024

CIPLA LTD. - 500087 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) and other applicable regulations of the SEBI (listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Registrar and Share Transfer agent of the Company M/S KFin Technologies Limited has received intimation for loss of share certificate and request for issuance of duplicate share certificates
26 Feb 2024

Cipla Gets CDSCO Nod For Antibiotic To Treat Complicated Urinary Tract Infections

Plazomicin is a new intravenous (IV) aminoglycoside indicated for the treatment of Complicated Urinary Tract Infections, including pyelonephritis.
Bigul
16 Feb 2024

CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operations and Administrative Committee of the Company on 15th February, 2024 has allotted 5,863 fully paid-up equity shares of INR 2 each, pursuant to exercise of ESOPs / ESARs under the Employee Stock Option Scheme 2013-A and Cipla Employee Stock Appreciation Rights Scheme 2021 of the Company. Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to INR 1,61,47,30,808 comprising of 80,73,65,404 equity shares of face value INR 2 each.
16 Feb 2024

Cipla Partners With CSIR-CDRI To Develop Formulation For Fungal Keratitis

The collaboration aims to leverage the combined expertise and resources of both organisations to develop a safe and efficacious drug for fungal keratitis, the Mumbai-based drug maker said in a statement.
14 Feb 2024

Cipla Expects To Sustain 24% Ebitda Margin, Says Management

The company is looking to organically expand in India by increasing focus on chronic prescription.
Bigul
13 Feb 2024

CIPLA LTD. - 500087 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation regarding issuance of Letter of Confirmation under Regulation 39(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 ("Listing Regulation").
Bigul
13 Feb 2024

CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Investor Presentation

In furtherance to our intimation dated 1st December 2023 with respect to our participation at the Nuvama India Conference 2024, the presentation to be discussed at the conference is enclosed and the same is also available on our website at www.cipla.com.
See all News

FAQs

The latest market price of Cipla Ltd. on NSE was Rs. 1470.90 as of today.

The opening share price of Cipla Ltd. was Rs. 1494.00 as of today.

The 52-week high share price of Cipla Ltd. was Rs. 1494.00.

The 52 week low share price of Cipla Ltd. was Rs. 852.00.

Cipla Ltd. has a market cap of Rs. 118755.40 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Cipla Ltd. is 0.80. Please refer to the Fundamentals section for further details.

The operating revenue for Cipla Ltd. in the last FY was Rs.  25350.15 crore. Please refer to the Financials section for further details.

The Net Profit for Cipla Ltd. in the last FY was Rs. 3704.02 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Cipla Ltd. was on 2023-07-21 for Rs. 8.5 per share. According to today’s share price, the dividend yield of Cipla Ltd. stands at 0.60. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Cipla Ltd. was as of 2006-04-24. The bonus ratio declared in this issue was 3:2. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Cipla Ltd. was as of 2004-05-11. The split ratio declared in this issue was 10:2. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Cipla Ltd..